A comprehensive study of polymorphisms in the ABCB1, ABCC2, ABCG2, NR1I2 genes and lymphoma risk

International Journal of Cancer

Volumn 131, Issue 4, 2012, Pages 803-812

  Campa, Daniele ^a   Butterbach, Katja ^a   Slager, Susan L ^b   Skibola, Christine F ^c   De Sanjosé, Silvia ^d,e   Benavente, Yolanda ^d,e   Becker, Nikolaus ^a   Foretova, Lenka ^f   Maynadie, Marc ^g   Cocco, Pierluigi ^h   Staines, Anthony ⁱ   Kaaks, Rudolf ^a   Boffetta, Paolo ^j,k   Brennan, Paul ^l   Conde, Lucia ^c   Bracci, Paige M ^m   Caporaso, Neil E ⁿ   Strom, Sara S ^o   Camp, Nicola J ^p   Cerhan, James R ^b   Consortium, Gec ^h   Canzian, Federico ^a   Nieters, Alexandra ^q,r   more..

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b MAYO CLINIC   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d CATALAN INSTITUTE OF ONCOLOGY   (Spain)

^e CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^f MASARYK MEMORIAL CANCER INSTITUTE   (Czech Republic)

^g UNIVERSITÉ DE BOURGOGNE   (France)

^h UNIVERSITY OF CAGLIARI   (Italy)

ⁱ DUBLIN CITY UNIVERSITY   (Ireland)

^j MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^k INTERNATIONAL PREVENTION RESEARCH INSTITUTE   (France)

^l INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^m UNIVERSITY OF CALIFORNIA   (United States)

ⁿ NATIONAL CANCER INSTITUTE   (United States)

^o UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^p UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^q UNIVERSITY OF FREIBURG   (Germany)

^r UNIVERSITY OF FREIBURG   (Germany)

more..

Author keywords

breast cancer resistance protein; lymphoma; multidrug resistance 1; multidrug resistance protein 2; pregnane x receptor

Indexed keywords

BREAST CANCER RESISTANCE PROTEIN; CELL NUCLEUS RECEPTOR; MULTIDRUG RESISTANCE PROTEIN 1; MULTIDRUG RESISTANCE PROTEIN 2; NUCLEAR RECEPTOR 1; NUCLEAR RECEPTOR 2; UNCLASSIFIED DRUG;

ABCB1 GENE; ABCC2 GENE; ABCG2 GENE; ADULT; AGED; ALLELE; ARTICLE; B CELL LYMPHOMA; CANCER RISK; CHRONIC LYMPHATIC LEUKEMIA; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME REGULATION; FEMALE; FOLLICULAR LYMPHOMA; GENE ACTIVITY; GENE EXPRESSION; GENE FUNCTION; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HODGKIN DISEASE; HUMAN; LARGE CELL LYMPHOMA; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MANTLE CELL LYMPHOMA; MARGINAL ZONE LYMPHOMA; NR1 GENE; NR1I2 GENE; NR2 GENE; ONCOGENE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; T CELL LYMPHOMA;

ATP-BINDING CASSETTE TRANSPORTERS; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; LYMPHOMA; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; NEOPLASM PROTEINS; P-GLYCOPROTEIN; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, STEROID; RISK FACTORS;

EID: 84862552868     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.26436     Document Type: Article

References (50)

1. Turner JJ, Morton LM, Linet MS, Clarke CA, Kadin ME, Vajdic CM, Monnereau A, Maynadie M, Chiu BC, Marcos-Gragera R, Costantini AS, Cerhan JR, et al. InterLymph hierarchical classification of lymphoid neoplasms for epidemiologic research based on the WHO Classification (2008): update and future directions. Blood 2010.
2. Jaffe ES, HNL, Stein H, Vardiman JW,. Pathology and genetics of tumours of heamatopoietic and lymphoid tissues. Lyon: IARC Press, 2001.
3. Alexander DD, Mink PJ, Adami HO, Chang ET, Cole P, Mandel JS, Trichopoulos D,. The non-Hodgkin lymphomas: a review of the epidemiologic literature. Int J Cancer 2007; 120 (Suppl 12): 1-39. (Pubitemid 46732571)
4. Wang SS, Slager SL, Brennan P, Holly EA, De Sanjose S, Bernstein L, Boffetta P, Cerhan JR, Maynadie M, Spinelli JJ, Chiu BC, Cocco PL, et al. Family history of hematopoietic malignancies and risk of non-Hodgkin lymphoma (NHL): a pooled analysis of 10 211 cases and 11 905 controls from the International Lymphoma Epidemiology Consortium (InterLymph). Blood 2007; 109: 3479-88. (Pubitemid 46572538)
5. de Sanjose S, Benavente Y, Vajdic CM, Engels EA, Morton LM, Bracci PM, Spinelli JJ, Zheng T, Zhang Y, Franceschi S, Talamini R, Holly EA, et al. Hepatitis C and non-Hodgkin lymphoma among 4784 cases and 6269 controls from the International Lymphoma Epidemiology Consortium. Clin Gastroenterol Hepatol 2008; 6: 451-8. (Pubitemid 351447318)
6. Skibola CF, Bracci PM, Nieters A, Brooks-Wilson A, de Sanjose S, Hughes AM, Cerhan JR, Skibola DR, Purdue M, Kane E, Lan Q, Foretova L, et al. Tumor necrosis factor (TNF) and lymphotoxin-alpha (LTA) polymorphisms and risk of non-Hodgkin lymphoma in the InterLymph Consortium. Am J Epidemiol 2010; 171: 267-76.
7. Conde L, Halperin E, Akers NK, Brown KM, Smedby KE, Rothman N, Nieters A, Slager SL, Brooks-Wilson A, Agana L, Riby J, Liu J, et al. Genome-wide association study of follicular lymphoma identifies a risk locus at 6p21.32. Nat Genet 2010; 42: 661-4.
8. Agundez JA,. Polymorphisms of human N-acetyltransferases and cancer risk. Curr Drug Metab 2008; 9: 520-31. (Pubitemid 352025183)
9. Leslie EM, Deeley RG, Cole SP,. Toxicological relevance of the multidrug resistance protein 1, MRP1 (ABCC1) and related transporters. Toxicology 2001; 167: 3-23. (Pubitemid 32830943)
10. Sheweita SA, Tilmisany AK,. Cancer and phase II drug-metabolizing enzymes. Curr Drug Metab 2003; 4: 45-58. (Pubitemid 36131683)
11. Singh MS, Michael M,. Role of xenobiotic metabolic enzymes in cancer epidemiology. Methods Mol Biol 2009; 472: 243-64.
12. Ishikawa T,. The ATP-dependent glutathione S-conjugate export pump. Trends Biochem Sci 1992; 17: 463-8.
13. Abbott BL,. ABCG2 (BCRP) expression in normal and malignant hematopoietic cells. Hematol Oncol 2003; 21: 115-30. (Pubitemid 37305331)
14. Hediger MA, Romero MF, Peng JB, Rolfs A, Takanaga H, Bruford EA,. The ABCs of solute carriers: physiological, pathological and therapeutic implications of human membrane transport proteinsIntroduction. Pflugers Arch 2004; 447: 465-8. (Pubitemid 38241432)
15. Huls M, Russel FG, Masereeuw R,. The role of ATP binding cassette transporters in tissue defense and organ regeneration. J Pharmacol Exp Ther 2009; 328: 3-9.
16. Leslie EM, Deeley RG, Cole SP,. Multidrug resistance proteins: role of P-glycoprotein, MRP1, MRP2, and BCRP (ABCG2) in tissue defense. Toxicol Appl Pharmacol 2005; 204: 216-37. (Pubitemid 40552845)
17. Klaassen CD, Aleksunes LM,. Xenobiotic, bile acid, and cholesterol transporters: function and regulation. Pharmacol Rev 2010; 62: 1-96.
18. Kliewer SA, Goodwin B, Willson TM,. The nuclear pregnane X receptor: a key regulator of xenobiotic metabolism. Endocr Rev 2002; 23: 687-702. (Pubitemid 35191629)
19. Robey RW, To KK, Polgar O, Dohse M, Fetsch P, Dean M, Bates SE,. ABCG2: a perspective. Adv Drug Deliv Rev 2009; 61: 3-13.
20. Wada M,. Single nucleotide polymorphisms in ABCC2 and ABCB1 genes and their clinical impact in physiology and drug response. Cancer Lett. 2006; 234: 40-50. (Pubitemid 43348490)
21. Campa D, Pardini B, Naccarati A, Vodickova L, Novotny J, Forsti A, Hemminki K, Barale R, Vodicka P, Canzian F,. A gene-wide investigation on polymorphisms in the ABCG2/BRCP transporter and susceptibility to colorectal cancer. Mutat Res 2008; 645: 56-60.
22. Gardner ER, Ahlers CM, Shukla S, Sissung TM, Ockers SB, Price DK, Hamada A, Robey RW, Steinberg SM, Ambudkar SV, Dahut WL, Figg WD,. Association of the ABCG2 C421A polymorphism with prostate cancer risk and survival. BJU Int 2008; 102: 1694-9.
23. Hattori H, Suminoe A, Wada M, Koga Y, Kohno K, Okamura J, Hara T, Matsuzaki A,. Regulatory polymorphisms of multidrug resistance 1 (MDR1) gene are associated with the development of childhood acute lymphoblastic leukemia. Leuk Res 2007; 31: 1633-40. (Pubitemid 350051403)
24. Hu LL, Wang XX, Chen X, Chang J, Li C, Zhang Y, Yang J, Jiang W, Zhuang SM,. BCRP gene polymorphisms are associated with susceptibility and survival of diffuse large B-cell lymphoma. Carcinogenesis 2007; 28: 1740-4. (Pubitemid 47289036)
25. Jamroziak K, Mlynarski W, Balcerczak E, Mistygacz M, Trelinska J, Mirowski M, Bodalski J, Robak T,. Functional C3435T polymorphism of MDR1 gene: an impact on genetic susceptibility and clinical outcome of childhood acute lymphoblastic leukemia. Eur J Haematol 2004; 72: 314-21. (Pubitemid 38520728)
26. Jamroziak K, Robak T,. Pharmacogenomics of MDR1/ABCB1 gene: the influence on risk and clinical outcome of haematological malignancies. Hematology 2004; 9: 91-105. (Pubitemid 38697023)
27. Besson H, Brennan P, Becker N, Nieters A, De Sanjose S, Font R, Maynadie M, Foretova L, Cocco PL, Staines A, Vornanen M, Boffetta P,. Tobacco smoking, alcohol drinking and non-Hodgkin's lymphoma: A European multicenter case-control study (Epilymph). Int J Cancer 2006; 119: 901-8. (Pubitemid 44051456)
28. Barrett JC, Fry B, Maller J, Daly MJ,. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005; 21: 263-5. (Pubitemid 40202029)
29. de Bakker PI, Yelensky R, Pe'er I, Gabriel SB, Daly MJ, Altshuler D,. Efficiency and power in genetic association studies. Nat Genet 2005; 37: 1217-23. (Pubitemid 41568704)
30. Morisaki K, Robey RW, Ozvegy-Laczka C, Honjo Y, Polgar O, Steadman K, Sarkadi B, Bates SE,. Single nucleotide polymorphisms modify the transporter activity of ABCG2. Cancer Chemother Pharmacol 2005; 56: 161-72. (Pubitemid 40884271)
31. Gao X, Starmer J, Martin ER,. A multiple testing correction method for genetic association studies using correlated single nucleotide polymorphisms. Genet Epidemiol 2008; 32: 361-9. (Pubitemid 351656307)
32. Slager SL, Rabe KG, Achenbach SJ, Vachon CM, Goldin LR, Strom SS, Lanasa MC, Spector LG, Rassenti LZ, Leis JF, Camp NJ, Glenn M, et al. Genome-wide association study identifies a novel susceptibility locus at 6p21.3 among familial CLL. Blood 2011; 117: 1911-6.
33. Team RDC,. R: a language and environment for statistical computing. R Foundation for Statistical Computing Vienna: Austria, 2008.
34. Chen B, Wilkening S, Drechsel M, Hemminki K,. SNP-tools: a compact tool package for analysis and conversion of genotype data for MS-Excel. BMC Res Notes 2009; 2: 214.
35. Gabriel SB, Schaffner SF, Nguyen H, Moore JM, Roy J, Blumenstiel B, Higgins J, DeFelice M, Lochner A, Faggart M, Liu-Cordero SN, Rotimi C, et al. The structure of haplotype blocks in the human genome. Science 2002; 296: 2225-9. (Pubitemid 34680308)
36. Moore JH,. Computational analysis of gene-gene interactions using multifactor dimensionality reduction. Exp Rev Mol Diagn 004; 4: 795-803.
37. Cortez MA, Scrideli CA, Yunes JA, Valera ET, Toledo SR, Pavoni-Ferreira PC, Lee ML, Petrilli AS, Brandalise SR, Tone LG,. mRNA expression profile of multidrug resistance genes in childhood acute lymphoblastic leukemia. Low expression levels associated with a higher risk of toxic death. Pediatr Blood Cancer 2009; 53: 996-1004.
38. Kim JE, Singh RR, Cho-Vega JH, Drakos E, Davuluri Y, Khokhar FA, Fayad L, Medeiros LJ, Vega F,. Sonic hedgehog signaling proteins and ATP-binding cassette G2 are aberrantly expressed in diffuse large B-cell lymphoma. Mod Pathol 2009; 22: 1312-20.
39. Plasschaert SL, van der Kolk DM, de Bont ES, Kamps WA, Morisaki K, Bates SE, Scheffer GL, Scheper RJ, Vellenga E, de Vries EG,. The role of breast cancer resistance protein in acute lymphoblastic leukemia. Clin Cancer Res 2003; 9: 5171-7. (Pubitemid 37413566)
40. Szczuraszek K, Materna V, Halon A, Mazur G, Wrobel T, Kuliczkowski K, Maciejczyk A, Zabel M, Drag M, Dietel M, Lage H, Surowiak P,. Positive correlation between cyclooxygenase-2 and ABC-transporter expression in non-Hodgkin's lymphomas. Oncol Rep 2009; 22: 1315-23.
41. Dehghan A, Kottgen A, Yang Q, Hwang SJ, Kao WL, Rivadeneira F, Boerwinkle E, Levy D, Hofman A, Astor BC, Benjamin EJ, van Duijn CM, et al. Association of three genetic loci with uric acid concentration and risk of gout: a genome-wide association study. Lancet 2008; 372: 1953-61.
42. Korenaga Y, Naito K, Okayama N, Hirata H, Suehiro Y, Hamanaka Y, Matsuyama H, Hinoda Y,. Association of the BCRP C421A polymorphism with nonpapillary renal cell carcinoma. Int J Cancer 2005; 117: 431-4. (Pubitemid 41429566)
43. Phipps-Green AJ, Hollis-Moffatt JE, Dalbeth N, Merriman ME, Topless R, Gow PJ, Harrison AA, Highton J, Jones PB, Stamp LK, Merriman TR,. A strong role for the ABCG2 gene in susceptibility to gout in New Zealand Pacific Island and Caucasian, but not Maori, case and control sample sets. Hum Mol Genet 2010; 19: 4813-4819.
44. Tabara Y, Kohara K, Kawamoto R, Hiura Y, Nishimura K, Morisaki T, Kokubo Y, Okamura T, Tomoike H, Iwai N, Miki T,. Association of four genetic loci with uric acid levels and reduced renal function: the J-SHIPP Suita study. Am J Nephrol 2010; 32: 279-86.
45. Imai Y, Nakane M, Kage K, Tsukahara S, Ishikawa E, Tsuruo T, Miki Y, Sugimoto Y,. C421A polymorphism in the human breast cancer resistance protein gene is associated with low expression of Q141K protein and low-level drug resistance. Mol Cancer Ther 2002; 1: 611-6.
46. Kondo C, Suzuki H, Itoda M, Ozawa S, Sawada J, Kobayashi D, Ieiri I, Mine K, Ohtsubo K, Sugiyama Y,. Functional analysis of SNPs variants of BCRP/ABCG2. Pharm Res 2004; 21: 1895-903. (Pubitemid 39390103)
47. Mizuarai S, Aozasa N, Kotani H,. Single nucleotide polymorphisms result in impaired membrane localization and reduced atpase activity in multidrug transporter ABCG2. Int J Cancer 2004; 109: 238-46. (Pubitemid 38240926)
48. Sparreboom A, Loos WJ, Burger H, Sissung TM, Verweij J, Figg WD, Nooter K, Gelderblom H,. Effect of ABCG2 genotype on the oral bioavailability of topotecan. Cancer Biol Ther 2005; 4: 650-8.
49. Crowther-Swanepoel D, Broderick P, Di Bernardo MC, Dobbins SE, Torres M, Mansouri M, Ruiz-Ponte C, Enjuanes A, Rosenquist R, Carracedo A, Jurlander J, Campo E, et al. Common variants at 2q37.3, 8q24.21, 15q21.3 and 16q24.1 influence chronic lymphocytic leukemia risk. Nat Genet 2010; 42: 132-6.
50. Di Bernardo MC, Crowther-Swanepoel D, Broderick P, Webb E, Sellick G, Wild R, Sullivan K, Vijayakrishnan J, Wang Y, Pittman AM, Sunter NJ, Hall AG, et al. A genome-wide association study identifies six susceptibility loci for chronic lymphocytic leukemia. Nat Genet 2008; 40: 1204-10.